| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
Search
|
|
| |
Antiviral Drug Discovery & Development | |
| |
December 30, 2002 |
Others |
|
| |
|
|
| |
Strategic Research Institute, Hyatt Regency Princeton, NJ
March 26th-27th, 2003
ORGANIZED INTO THREE SECTIONS: * HIV INFECTION
* HEPATITIS B & C
* RESPIRATORY & OTHER VIRUS INFECTIONS
|
|
|
|
|
|
|
|
Organized by:
|
|
Ed Drilon |
|
|
Invited Speakers:
|
|
FEATURING: Bristol-Myers Squibb
Boehringer Ingelheim Pharmaceuticals
Crucell Holland
Eli Lilly & Company
Gilead Sciences
Hoffman-La Roche
Human Genome Sciences Inc.
ICN Pharmaceuticals (Ribapharm)
Idenix (Novirio) Pharmaceuticals
Message Pharmaceuticals
Merck Research Laboratories
Panacos Pharmaceuticals
Pfizer-La Jolla (Agouron)
Pharmasset Inc.
Trimeris Inc.
Emory Univ. School of Medicine
Oregon Health & Science Univ.
Veterans Affairs Medical Ctr.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
tba
|
|
|
|
|
|
|
|
Registration:
|
|
www.srinstitute.com
|
|
|
E-mail:
|
|
edrilon@srinstitute.com
|
|
|
|
|
|
|
| |
Posted by:
|
|
Jennifer Law
|
|
|
Host:
|
|
12.3.58.15
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|